HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liangdong Jiang Selected Research

Drug Therapy (Chemotherapy)

12/2015MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liangdong Jiang Research Topics

Disease

2Osteosarcoma (Osteogenic Sarcoma)
12/2015 - 12/2014
1Inflammation (Inflammations)
09/2023
1Ulcer
09/2023
1Wounds and Injuries (Trauma)
09/2023
1Osteoarthritis
01/2023
1Neoplasm Metastasis (Metastasis)
12/2014
1Neoplasms (Cancer)
12/2014
1Carcinogenesis
12/2014

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
12/2015 - 12/2014
1Blood Glucose (Blood Sugar)IBA
09/2023
1CollagenIBA
09/2023
1paeonolIBA
09/2023
1Glucose (Dextrose)FDA LinkGeneric
09/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2023
1MicroRNAs (MicroRNA)IBA
01/2023
1Methotrexate (Mexate)FDA LinkGeneric
12/2015
1Sirolimus (Rapamycin)FDA Link
12/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2014
1Metalloproteases (Metalloproteinases)IBA
12/2014
1DisintegrinsIBA
12/2014
1Small Interfering RNA (siRNA)IBA
12/2014

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2015